PLoS ONE (Jan 2017)

Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.

  • Weimei Xing,
  • Ona Barauskas,
  • Thorsten Kirschberg,
  • Anita Niedziela-Majka,
  • Michael Clarke,
  • Gabriel Birkus,
  • Perry Weissburg,
  • Xiaohong Liu,
  • Brian E Schultz,
  • Roman Sakowicz,
  • HyockJoo Kwon,
  • Joy Y Feng

DOI
https://doi.org/10.1371/journal.pone.0181969
Journal volume & issue
Vol. 12, no. 8
p. e0181969

Abstract

Read online

Influenza polymerase is a heterotrimer composed of polymerase acidic protein A (PA) and basic proteins 1 (PB1) and 2 (PB2). The endonuclease active site, located in the PA subunit, cleaves host mRNA to prime viral mRNA transcription, and is essential for viral replication. To date, the human influenza A endonuclease activity has only been studied on the truncated active-site containing N-terminal domain of PA (PAN) or full-length PA in the absence of PB1 or PB2. In this study, we characterized the endonuclease activity of recombinant proteins of influenza A/PR8 containing full length PA, PA/PB1 dimer, and PA/PB1/PB2 trimer, observing 8.3-, 265-, and 142-fold higher activity than PAN, respectively. Using the PA/PB1/PB2 trimer, we developed a robust endonuclease assay with a synthetic fluorogenic RNA substrate. The observed Km (150 ± 11 nM) and kcat [(1.4 ± 0.2) x 10-3s-1] values were consistent with previous reports using virion-derived replication complex. Two known influenza endonuclease phenylbutanoic acid inhibitors showed IC50 values of 10-20 nM, demonstrating the utility of this system for future high throughput screening.